24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Digital health products are transforming the healthcare landscape and providing patients with new ways to manage and treat conditions. However, they come with several important considerations for medical communicators, especially when compared with traditional pharmaceuticals, explains Principal Medical Writer Caroline Leitschuh.
Oxford PharmaGenesis has been honoured with the first ever King’s Award for Enterprise, the most prestigious business award in the country, which recognizes the company’s excellence in International Trade.
PubMed is a website that files scientific research articles and shows their abstracts. PubMed can also show plain language summaries (PLS) of these articles when publishers tag the PLS correctly. PLS and open access, or free-to-read, publishing can help readers to find and use published research. In this study, we downloaded all of the available…
Effective innovation happens when we ask big questions. It’s part of what makes Oxford PharmaGenesis an award-winning, independent, global HealthScience communications consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration, Open Pharma, social media, and more.
News stories about science sometimes use exaggerated wording that was not used by the scientists themselves – words like ‘astonishing’ or ‘miracle’, for example. Words like these might lead to a science story ‘going viral’ across social media and other new sites, but could also lead to the public being misled and might foster distrust…
Pharmaceutical companies help humans stay healthy, so we wondered what they are doing for planetary health, by focusing on the greenhouse gas emissions produced by pharmaceutical companies that are adding to climate change.
